Introduction
The cell cycle is a complex process that involves numerous regulatory proteins, including cyclins, cyclindependent kinases (CDKs) and CDK inhibitors. CDK inhibitors provide one of the mechanisms for inactivating CDKs. They include the WAF1/CIP/KIP family and INK4 family (Blagosklonny et al., 1996; Sherr and Roberts, 1999) . The p21
Cip1/WAF1 is a member of the Cip/Kip family of proteins that includes p21, p27 and p57, which promote cell cycle arrest by binding to and inhibiting CDKs. The p21 regulates many cellular processes, such as cell cycle arrest, DNA replication and repair, cell proliferation and differentiation, senescence and apoptosis Dotto, 2000; Gartel and Tyner, 2002; O'Reilly, 2005) . In addition, p21 is considered a major mediator of the G1 growth arrest induced by activation of p53 in response to DNA damage (el-Deiry et al., 1993; el-Deiry et al., 1994) . The expression of p21 is controlled by p53-dependent and -independent mechanisms at the transcriptional level (el-Deiry et al., 1993; Sheikh et al., 1994; Parker et al., 1995; Shiohara et al., 1996) , whereas the post-transcriptional control of p21 is mainly mediated by phosphorylation, ubiquitination and localization (Li et al., 1996; Zhou et al., 2001; Child and Mann, 2006) . As a labile protein, p21 is degraded by the proteasome in ubiquitin-dependent and -independent manners (Blagosklonny et al., 1996; Maki and Howley, 1997; Fukuchi et al., 1999; Touitou et al., 2001) .
Recently, the second human single-stranded binding protein, SSB1 (hSSB1; OBFC2B), was identified as a key player in the cellular response to DNA damage: hSSB1 depletion results in increased radiosensitivity, defective checkpoint activation and genomic instability (Richard et al., 2008) . Subsequently, the INTS3-hSSB1-MISE complex was identified to have key roles in DNA double-strand break repair after DNA damage (Huang et al., 2009; Li et al., 2009; Skaar et al., 2009; Zhang et al., 2009) . However, the molecular mechanisms by which hSSB1 functions in response to DNA damage remain unknown. In this study, we report that hSSB1 binds and protects p21 from ubiquitin-mediated degradation, and this positive regulation of p21 by hSSB1 is also present in clinical samples of hepatocellular carcinomas (HCC).
Results
hSSB1 knockdown leads to decreased p21 protein Cells deficient in hSSB1 exhibit increased radiosensitivity, defective checkpoint activation and enhanced genomic instability along with a diminished capacity for DNA repair (Richard et al., 2008) . The mechanisms of these recently described phenomena, however, are unknown. To investigate how hSSB1 regulates the cell cycle checkpoint, a number of proteins that have key roles in cell cycle and DNA damage checkpoints were examined in HeLa cells with hSSB1 knocked down by small interfering (si)RNA. As shown in Figure 1a , p21 was markedly reduced, whereas the other proteins, cyclin A, cyclin B1, cyclin E, Cdc2, CDK2, CDK4 and PCNA, remained constant. To avoid off-target effects, three different siRNA duplexes specifically targeting different hSSB1 coding regions were used, and each individual siRNA validated this unexpected finding (Figure 1b) . Interestingly, this positive regulation of p21 by hSSB1 did not occur at the transcriptional level, as the mRNA level of p21 was not altered in hSSB1-knockdown HeLa cells (Figure 1c) . Moreover, this positive correlation between hSSB1 and p21 was extended to multiple cancer cell lines, such as U2OS (p53-wildtype), Saos-2 (p53-null), CNE2 (p53-mutant), HepG2 (p53-wildtype), SMMC-7721 (p53-wildtype) and Bel-7402 (p53-wildtype) cells (Figure 1d ). Given that p53 is major regulator of p21 at the transcriptional level and that the tested cell lines include both p53-wildtype and -deficient cells, these results suggest that hSSB1 may positively regulate p21 at the post-transcriptional level, independent of p53.
Mapping of the domains responsible for the interaction between hSSB1 and p21 Next, the interaction between hSSB1 and p21 was tested. First, using co-immunoprecipitation, a complex containing hSSB1 and p21 was clearly detected using Flag-agarose or HA-agarose in HEK293T cells overexpressing both Flag-tagged hSSB1 and HA-tagged p21 (Figure 2a) . Second, as expected, hSSB1 co-localized with p21 in the nuclei, as detected by immunofluorescence ( Figure 2b ). Most importantly, the complex containing hSSB1 and p21 was detectable at their endogenous levels, as shown in Figure 2c . In addition, this interaction between hSSB1 and p21 appears to be direct, as recombinant GST-hSSB1 binds recombinant GST-p21 in vitro (Figure 2d ). Collectively, these results indicate that hSSB1 may physically interact with p21 in vitro and in vivo.
Next, a series of deletions of hSSB1 and p21 were generated (Figures 3a and d) , and co-immunoprecipitation was performed to map the binding domains of the two proteins. As shown in Figures 3a-c , both the N-terminal oligosaccharide-binding-fold domain (residues 1-113) and the C-terminal (114-211) of hSSB1 were capable of binding p21. However, as shown in Figures 3d-f , the N-terminal of p21 (residues 1-90) was necessary and sufficient to bind hSSB1. These results reinforce the hypothesis that hSSB1 physically and specifically interacts with p21 in cells.
hSSB1 protects p21 from ubiquitin-mediated degradation As hSSB1 binds p21 and positively regulates p21 protein level and p21 is a labile protein degraded by the proteasome, we surmised that hSSB1 might affect p21 protein stability. Indeed, MG132, a specific proteasome inhibitor, substantially rescued the decline of p21 protein caused by hSSB1 knockdown in HeLa cells hSSB1 binds and protects p21 from ubiquitin-mediated degradation S Xu et al (Figure 4a ), suggesting that hSSB1 prevents p21 from degradation by the proteasome. Furthermore, as shown in Figure 4b , the polyubiquitinated p21 was upregulated in hSSB1-knockdown HeLa cells, indicating that the degradation of p21 prevented by hSSB1 is ubiquitination dependent. Consistent with this notion, the half-life of endogenous p21 protein became shorter in hSSB1-knockdown HeLa cells in the presence of cycloheximide, an inhibitor of protein synthesis (Figure 4c ). Taken together, these results indicate that hSSB1 positively regulates p21 by protecting p21 from the ubiquitinproteasome system. Ubiquitin-mediated degradation of p21 depends on three E3 ubiquitin ligase complexes, SCF SKP2 , CRl4
CDT2
and APC/C CDC20 , at different phases in an unperturbed cell cycle (Abbas and Dutta, 2009 ). To determine which E3 ubiquitin ligase complex is regulated by hSSB1, hSSB1-knockdown cells were synchronized at each phase. As shown in Figure 4d , knockdown of hSSB1 always resulted in a decrease in p21 at each phase, although p21 protein level varied during the cell cycle. This indicates that hSSB1 may protect p21 from ubiquitin-mediated degradation by acting as a cellular companion or chaperone for p21. In other words, protection of p21 by hSSB1 is independent of the cell cycle.
Regulation of both the G1/S transition and the G2/M checkpoint by hSSB1 partially depends on p21 To determine the biological functions of the interaction between hSSB1 and p21, cell cycle progression and DNA damage checkpoints were monitored, as both hSSB1 and p21 are key components in these processes. As shown in Figure 5a , the percentage of cells at S phase was increased when hSSB1 or p21 was knocked down. This is consistent with p21 being a major inhibitor of the G1/S transition during cell cycle, as downregulation of hSSB1 decreased p21 level. Interestingly, ectopic expression of hSSB1 did not alter the cell cycle distribution nor the expression of p21 (Supplementary Figure S1) , indicating that adequate endogenous hSSB1 may be present to execute its functions in cell cycle regulation. Next, we determined whether the increased S-phase cells are due to promoted G1/S transition or prolonged Sphase block. The percentage of cells at G1 and S phase was measured by flow cytometry using HepG2 cells (p53-wildtype) treated with nocodazole or hydroxyurea, which arrests cells at M phase or early S phase, respectively. As shown in Figure 5b , the percentage of cells at G1 phase was remarkably decreased by hSSB1 knockdown, whereas the S-phase cells (positive for bromodeoxyuridine (BrdU) incorporation) were marginally changed, strongly indicating that downregulation of hSSB1 significantly promoted the G1/S transition. More importantly, depletion of hSSB1 did not significantly alter the percentage of cells at G1 phase using the cells knockdown of p21 by siRNA ( Figure 5c ). Moreover, as shown in Figure 5c and Supplementary Figure S2 , the enhanced transition from G1 to S caused by knockdown of hSSB1 was substantially rescued by overexpressing of p21 in these cells. These results strongly suggest that the enhanced G1/S transition Immunoprecipitation (IP) using anti-HA or anti-Flag antibodies and western blotting with the indicated antibody were performed (n ¼ 3). WCL, whole cell lysate. (b) Subcellular localization of endogenous hSSB1 (green) and p21 (red) in paraformaldehyde-fixed HepG2 cells visualized by immunofluorescence using anti-hSSB1 and anti-p21 antibodies. DNA staining with Hoechst 33342 and a merged view of red and green channels of the same field is shown (merge) (n ¼ 3). (c) HepG2 cells were lysed with MCLB, and lysates were subjected to immunoprecipitation using anti-immunoglobulin G or anti-hSSB1 as indicated, and were analyzed by western blotting (n ¼ 3). (d) GST, GST-p21 and GST-hSSB1 produced from bacteria were monitored by western blotting (lanes 1-3), and anti-p21 antibodies were used to immobilize purified GST-p21 protein onto protein A beads and then incubated with purified GST (lane 4) or GST-hSSB1(lane 5). The beads were washed five times and bound proteins were analyzed by western blot using anti-GST antibodies (n ¼ 2).
hSSB1 binds and protects p21 from ubiquitin-mediated degradation S Xu et al induced by knockdown of hSSB1 is partially dependent on p21.
To further establish a functional connection between hSSB1 and p21, we tested whether p21 is required for the functions of hSSB1 in the DNA damage checkpoints. As shown in Figure 5d , ionizing radiation (IR)-induced increase of p21 was completely suppressed in hSSB1-knockdown cells (Figure 5d ). However, using HeLa cells, hSSB1 depletion did not affect p21 at the transcriptional level in IR-irradiated cells, as shown in Supplementary Figure S3 . This is similar to the report by Jascur T et al., showing that WISp39 is required for the stability of p21 and for IR-induced accumulation of p21 (Jascur et al., 2005) . Phospho-Ser10-histone3 (pH3), an indicator of cells at M phase, was used to monitor the G2/M checkpoint in HeLa cells (p53-deficient) exposed to IR. As shown in Figure 5e , the percentage of cells at M phase was remarkably increased by knockdown of hSSB1, suggesting that downregulation of hSSB1 abrogates the G2/M checkpoint. Likewise, the percentage of cells at M phase was also significantly increased by knockdown of p21. However, depletion of hSSB1 had minimal effect on the increased percentage of cells at M phase when the cells were knockdown of p21 by siRNA (Figure 5e ), indicating that the abrogation of G2/M checkpoint by downregulating of hSSB1 depends on p21. Indeed, such an abolishment of the G2/M checkpoint by hSSB1 knockdown was completely rescued by overexpressing of p21 in these cells, as shown in Figure 5f . Collectively, these results strongly suggest that knockdown of hSSB1 enhances the G1/S transition and abolishes the G2/M checkpoint by promoting p21 protein degradation.
hSSB1 is overproduced and positively correlates with p21 expression in clinical samples of hepatocellular carcinoma Finally, the significance of the interaction between hSSB1 and p21 in human pathophysiology was determined by immunohistochemistry using 100 pairs of HCC tissues. Both hSSB1 and p21 were mainly located in the nuclei of the cancer cells and were highly expressed in the HCC tissues (Figure 6a ). This result was consistent with the majority of previous studies showing that the tumor cells of HCC exhibited positive nuclear staining of p21 (Qin et al., 1998; SchonigerHekele et al., 2005; Kao et al., 2007; Lee et al., 2009) . However, some reports have showed cytoplasmic p21 staining in HCC (Tanaka et al., 2002; Lee and Helfman, 2004; Shiraki and Wagayama, 2006) , and we also observed a weak cytoplasmic p21 staining in three cases (3%) of HCC tissues that were excluded in our statistical analyses in this report. Moreover, our results revealed that high expression (positive) of hSSB1 and of p21 in hSSB1 binds and protects p21 from ubiquitin-mediated degradation S Xu et al HCC tissues were 64 and 40%, respectively, whereas the respective levels in the corresponding adjacent hepatic tissues were 40 and 14%. The expression of hSSB1 and p21 in HCC was significantly higher than in adjacent hepatic tissues (Po0.05) (Figure 6b ). There was no correlation between hSSB1 or p21 expression and the clinical parameters, including gender, age, tumor size, HBsAg, pathologic grade and serum level of a-fetoprotein (P40.05) (data not shown). The associations between survival time and hSSB1 overexpression in HCC were analyzed with Kaplan-Meier survival analysis. Our results showed that there was no significant correlation between hSSB1 expression and the survival time of the HCC patients (data not shown). hSSB1 binds and protects p21 from ubiquitin-mediated degradation S Xu et al Figure 5 Regulation of both the G1/S transition and the G2/M checkpoint by hSSB1 depends on p21. (a) HeLa or HepG2 cells were transfected with scrambled, hSSB1 or p21 siRNA for 48 h, and the cells were stained with propidium iodide and analyzed by flow cytometry (n ¼ 3). (b) HepG2 cells were transfected with scrambled or hSSB1 siRNA for 48 h in the presence of nocodazole (100 ng/ml) or hydroxyurea (HU, 2.5 mM) for additional 16 or 18 h, as indicated. Cell cycle profiles were analyzed using flow cytometry. The numbers depict percentages of cells in each phase (n ¼ 3). (c) Upper: HepG2 cells were transfected by scrambled or hSSB1 siRNA combined with si-p21 for 32 h and then were incubated with nocodazole (100 ng/ml) for 16 h. Lower: HepG2 cells transfected with scrambled or hSSB1 siRNA for 24 h were transfected with p21-WT or control as indicated for 8 h, and then nocodazole (100 ng/ml) was added for another 16 h, followed by analysis as in b (n ¼ 3). (d) HeLa or HepG2 cells transfected with scrambled or hSSB1 siRNA for 24 h were either untreated or irradiated (10 Gy). After 24 h, cells were then harvested in MCLB and analyzed by immunoblotting.
(e) HeLa cells were transfected by scrambled or hSSB1 siRNA together with scrambled or p21siRNA for 48 h and then exposed to IR (10 Gy). They were then incubated with 100 ng/ml of nocodazole for 22 h, harvested and analyzed using flow cytometry. The percentage of cells positive for phosphohistone H3 (pH3) is indicated (n ¼ 3). (f) HeLa cells transfected with scramble or hSSB1 siRNA for 24 h were transfected with p21 or vector. After 24 h, cells were exposed to IR (10 Gy), incubated with 100 ng/ml of nocodazole for 22 h, and analyzed as in e (n ¼ 3). All the results shown are representative of three independent experiments.
hSSB1 binds and protects p21 from ubiquitin-mediated degradation S Xu et al
Given that both hSSB1 and p21 are overproduced in HCC and that hSSB1 positively regulates p21 protein level in cancer cell lines, including liver cancer cell lines such as HepG2, SMMC-7721 and Bel-7402, we calculated the correlation between hSSB1 and p21 expression in 100 pairs of HCC tissues by Spearman correlation analysis. As shown in Figures 6a and b , high expression of p21 was detected in some HCC tissues when hSSB1 was high (for example, case 1), whereas both p21 and hSSB1 were simultaneously low in some HCC tissues (for example, case 2). As shown in Figure 6c , a statistically significant positive correlation was observed between hSSB1 and p21 expression in HCC tissues (P ¼ 0.001). Interestingly, seven HCC tissues contained low levels of hSSB1 but stained positive for p21, demonstrating that other proteins in addition to hSSB1 may also be involved in p21 overproduction in human HCC.
Discussion
In this report, we have revealed that hSSB1 binds and protects p21 from ubiquitin-mediated degradation, regulating cell cycle progression and DNA damage checkpoints. To our knowledge, this is the first evidence that hSSB1 may positively regulate the stability of p21 as a companion or chaperone, providing an explanation for why hSSB1 knockdown abrogates the G1/S transition or G2/M checkpoint by promoting p21 protein degradation. Furthermore, this positive relationship between hSSB1 and p21 is also detectable in human HCC, implicating hSSB1 as a novel, promising therapeutic target for cancers such as HCC.
As a key regulator of the cell cycle, p21 is tightly controlled at multiple levels. At the transcriptional level, p21 is regulated by p53-dependent and -independent mechanisms (el-Deiry et al., 1994; Sheikh et al., 1994; Parker et al., 1995; Shiohara et al., 1996) . Phosphorylation, ubiquitination and localization are the major methods of post-transcriptional control of p21 (Li et al., 1996; Zhou et al., 2001; Child and Mann, 2006) . For instance, in actively dividing cells, p21 is degraded by three E3 ubiquitin ligase complexes, SCF SKP2 (SKP1-Cul1-SKP2), CRl4 CDT2 (Cul4A or Cul4B-DDB1-CDT2) and APC/C CDC20 (Abbas and Dutta, 2009 ). Multiple p21-binding proteins have been identified, and some of them that mediate various functions share overlapping binding sites on p21 (Child and Mann, 2006) . For example, MDM2 interacts with and promotes p21 degradation (Jin et al., 2003) , whereas WISp39 and NPM/B23 bind p21 and increase p21 stability (Jascur et al., 2005; Xiao et al., 2009) . We have demonstrated that hSSB1, a recently identified key component in DNA damage checkpoints, behaves similar to WISp39 and NPM/B23, and that this positive regulation of p21 by hSSB1 is independent of the cell cycle at the posttranscriptional level. Taken together, these data indicate that the p21 binding partners, such as WISp39, NPM/ B23 and hSSB1, may act as companions or chaperones to protect p21 from ubiquitin-mediated proteolysis, highlighting this emerging regulatory pathway of p21 stability. Consistent with this notion, ectopic expression of hSSB1 did not affect the endogenous Cdk1 activity, as shown in Supplementary Figure S4 .
Previous studies have reported that IR induces a p53-dependent or -independent increase of p21 protein hSSB1 binds and protects p21 from ubiquitin-mediated degradation S Xu et al in cancer cells (Dulic et al., 1994; el-Deiry et al., 1994; Michieli et al., 1994; Macleod et al., 1995; Bunz et al., 1998; Moustakas and Kardassis, 1998) . Our results show that hSSB1 is required to stabilize p21 during the G1/S transition in the undisrupted cell cycle and in response to IR, and this function is also independent of p53. More importantly, we found that hSSB1 knockdown promotes the G1/S transition and bypasses the G2/M checkpoint response to IR, which was substantially rescued by overexpressing p21 in these cells. These findings indicate that hSSB1 knockdown disrupts cell cycle regulation and DNA damage checkpoints by promoting p21 degradation, providing new insight into the regulation of the p21 protein level during the cell cycle and in response to DNA damage.
It is reported that INTS3, a protein encoded by INTS3 gene that is one of the frequently amplified genes in HCC, can bind and regulate hSSB1 transcription and protein expression (Inagaki et al., 2008) . Our results showed that hSSB1 is overexpressed in HCC. Therefore, hSSB1 and INTS3 may cooperatively contribute to development of HCC. Although p21 was initially considered as an important tumor suppressor, it may also act as an oncogene (Gartel, 2006) . For instance, p21 is overexpressed in a variety of cancers, including breast, HCC, prostate, cervical, gliomas and squamous cell carcinomas. In many cases, p21 upregulation positively correlates with tumor grade, invasiveness and aggressiveness and is a poor prognostic indicator (Abbas and Dutta, 2009 ). Although there is no direct evidence suggesting that p21 upregulation contributes to the development of these cancers, it may be involved in their resistance to chemotherapy and radiotherapy (Liu et al., 2003) . Our results demonstrate that hSSB1 and p21 are overproduced and there is a strong positive correlation between hSSB1 and p21 in clinical samples of HCC, indicating that hSSB1 may be involved in the development and progression of HCC. To our knowledge, this is the first report about the expression of hSSB1 in human tumor tissues. Given that hSSB1 has a key role in radiosensitivity, checkpoint activation and genomic instability (Richard et al., 2008) , we speculate that hSSB1 may be a promising molecular target for novel treatments for cancers such as HCC.
Materials and methods

Cell lines
Cells (HeLa, HepG2, HEK293, HEK293T, U2OS, Saos-2, CNE-2, SMMC-7721 and Bel-7402) were cultured in Dulbecco's modified Eagle's medium (Invitrogen, Camarillo, CA, USA) supplemented with 10% fetal bovine serum (HyClone, Logan, UT, USA), 1 mM glutamine and 100 U/ml each of penicillin and streptomycin.
Clinical samples
Samples from 100 Chinese patients with HCC and their clinical records from 1997 to 2004 were collected from Sun Yat-Sen University Cancer Center, Guangzhou, China. Ages of the patients with HCC ranged from 17 to 71 years. Tissue blocks prepared from HCC tissues and the adjacent liver tissues were sectioned for performing immunohistochemistry for hSSB1 and p21.
Plasmids
Full-length hSSB1 and p21 complementary DNAs were cloned into pcDNA3.1 with FLAG, HA or Myc tag from human HEK293 cells. GST-hSSB1 was constructed by inserting hSSB1 complementary DNA into the pGEX-4T-2 vector, and GST-p21 vector was used previously (Xiao et al., 2009) . HA-tagged ubiquitin was used previously (Kang et al., 2008) . Mutations were introduced using the Quick-Change SiteDirected Mutagenesis Kit (Stratagene, La Jolla, CA, USA), and all mutations were verified by DNA sequencing.
Antibodies
Antibodies specific for hSSB1 were generated by immunizing rabbits with the coupled peptide 198 CPVSNGKETRRSSKR. Human anti-cyclin A, anti-p21, anti-cyclin B1, anti-cyclin E, anti-Cdc2, anti-CDK2, anti-CDK4 and anti-Hsp70 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Human anti-FLAG and anti-actin antibodies were from Sigma Chemical Co. (St Louis, MO, USA) Human anti-PCNA and hSSB1 antibody were from Bethyl Laboratories (Montgomery, TX, USA). Human anti-BrdU monoclonal antibody was purchased from BD Biosciences (San Jose, CA, USA). Other primary antibodies used for western blotting (anti-HA, antip21, anti-Myc and anti-GST) were from Cell Signaling Technology (Beverly, MA, USA). Bound primary antibodies were detected with either horseradish peroxidase-conjugated goat anti-mouse antibody or horseradish peroxidase-conjugated goat anti-rabbit antibody (Sigma Chemical Co.). Proteins were visualized by chemiluminescence.
Transfection experiments
Transfection was performed as described previously (Kang et al., 2008) . Briefly, asynchronously growing cells seeded at 2.5 Â 10 5 cells per well of a six-well tissue culture dish or at 1 Â 10 6 cells per 10-cm tissue culture dish were transfected with 2 or 12 mg plasmid DNA, respectively, using Lipofectamine 2000 (Invitrogen).
Treatment of cells with chemical inhibitors
Asynchronously growing cells were incubated in media containing 10 mM MG132 at the indicated concentrations for 4 h. To obtain mitotic cells, cells were incubated with 100 ng/ml of nocodazole for 16-22 h. Cells were lysed in mammalian cell lysis buffer (MCLB: 50 mM Tris-HCl pH 8.0, 2 mM dithiothreitol, 5 mM EDTA, 0.5% Nonidet P-40, 100 mM NaCl, 1 mM microcystin, 1 mM sodium orthovanadate, 2 mM phenylmethylsulfonyl fluoride, protease inhibitor cocktail (Sigma Chemical Co.) and phosphatase inhibitor cocktail (Calbiochem, Darmstadt, Germany )). MG132 was purchased from Calbiochem. Hydroxyurea was purchased from Sigma Chemical Co. and BrdU was purchased from Amersham Pharmacia Biotech (Buckinghamshire, UK).
RNAi treatment
The sequence of the p21 siRNA has been reported (Miyazaki et al., 2004) . The sequences of oligonucleotides 1, 2 and 3, targeting hSSB1 mRNA, were CCCUGUUAGUAACGGC AAA, GGAGAAUUCUGUAUGGUU and CGACGGAGA CCUUUGUGAA, respectively. These siRNAs were synthesized by Invitrogen. Approximately 2 Â 10 5 HeLa cells were seeded per well of a six-well tissue culture dish the day before transfection. Transfection was performed according to the hSSB1 binds and protects p21 from ubiquitin-mediated degradation S Xu et al manufacturer's instructions using Lipofectamine RNAiMAX transfection reagent (Invitrogen) and 50 nM siRNA. At 48 h post-transfection, cells were incubated in the presence or absence of 25 mg/ml cycloheximide for the indicated times and harvested in MCLB. Alternatively, cells were exposed to 10 Gy IR and harvested in MCLB after 24 h.
Reverse transcription-PCR
Reverse transcription-PCR was performed as described previously (Xu et al., 2009 
Western blotting and immunoprecipitation
Western blotting and immunoprecipitation were performed as described previously (Kang et al., 2008) . Briefly, cells were lysed in MCLB, and clarified lysates were resolved by SDSpolyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes for western blotting using ECL detection reagents (Beyotime Co., Haimen, Jiangsu, China). Alternatively, clarified supernatants were first incubated with anti-Myc-agarose (Santa Cruz Biotechnology), anti-FLAG-agarose (Sigma Chemical Co.) or anti-HA-agarose (Sigma Chemical Co.) for 2 h to overnight at 4 1C, and precipitates were washed four times with MCLB. To investigate the interaction between hSSB1 and p21 at the endogenous level, the clarified supernatants were first incubated with antihSSB1 for 2 h at 4 1C. Then, protein A/G-agaroses were added for 2 h to overnight, and precipitates were washed four times with MCLB and analyzed by western blotting.
GST pulldown assays GST-hSSB1 and GST-p21 were purified from bacteria using glutathione-agarose beads (GE Healthcare, Uppsala, Sweden). Anti-p21 antibodies were used to immobilize GST-p21 onto protein A beads and incubated with GST or GST-hSSB1. After incubation overnight at 41C, the beads were washed five times and bound proteins were analyzed by western blotting.
In vivo ubiquitination assay HeLa cells were transfected with hSSB1 siRNA oligonucleotides or scrambled oligonucleotide. At 24 h after transfection, cells were co-transfected with the indicated Myc-p21 and HAubiquitin constructs for 24 h, and MG132 (10 mM) was added for 4 h before collection and lysed in MCLB. The clarified supernatants were first incubated with anti-Myc-agarose (Santa Cruz Biotechnology) and then subjected to western blotting.
Synchronization of HeLa cells
HeLa cells, synchronized at the G1/S boundary using a double thymidine block-and-release protocol (Chen et al., 2003) , were released into culture media for 3 h (S-phase cells), 6 h (G2-phase cells), 9 h with 100 ng/ml of nocodazole (M-phase cells) or 11 h (G1-phase cells). Cells were collected and analyzed by flow cytometry and western blotting.
Flow cytometry
Flow cytometry was performed as described previously (Kang et al., 2008) . Briefly, cells were harvested by trypsinization and collected by centrifugation. Cells were washed once with phosphate-buffered saline (PBS) and fixed in 1 ml of 70% ethanol at À20 1C. Cells were washed once with PBS/1% bovine serum albumin (BSA) and then incubated with 1 ml of PBS/1% BSA containing 30 mg/ml propidium iodide and 0.25 mg/ml RNase A for 30 min at room temperature. Cells were analyzed for DNA content by flow cytometry using a cytomics FC 500 (Beckman Coulter, Fullerton, CA, USA). The data were analyzed using Multicycle AV for windows software (Beckman).
G1/S transition assay
As detailed previously (Ivanovska et al., 2008) , HepG2 cells were transfected with a control siRNAs and hSSB1 siRNAs. After 24 h, p21-WT and control plasmid then were transfected. Nocodazole (100 ng/ml; Sigma-Aldrich, St Louis, MO, USA) was added 8 h after the second transfection for 16 h. Cells were harvested by trypsinization and fixed with 70% ethanol at À20 1C overnight. Cell cycle distributions were measured by staining with propidium iodide, followed by analysis on a flow cytometer (Beckman).
Brdu labeling
HeLa cells were first transfected with siRNAs for 30 h, then synchronized in early S phase with hydroxyurea (2.5 mM) for another 18 h. Cells were washed twice with PBS and incubated with 20 mM BrdU for 1 h and then processed for flow cytometry as described (Ferguson et al., 2005) .
G2/M checkpoint assay
Cells were first exposed to IR (10 Gy) and incubated with 100 ng/ml of nocodazole for 22 h and were then harvested and fixed in 70% ethanol at À20 1C. After fixation, the cells were resuspended in 1 ml of 0.25% Triton X-100 in PBS and incubated at 4 1C for 15 min with rocking. After centrifugation, the cell pellet was suspended in 100 ml of PBS containing 1% BSA and 0.75 mg of a polyclonal antibody that specifically recognizes the phosphorylated form of histone H3 (Upstate Biotechnology, Lake Placid, NY, USA) and incubated for 1.5 h at room temperature. The cells were then rinsed with PBS containing 1% BSA and incubated with fluorescein isothiocyanate-conjugated goat anti-rabbit antibody (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) diluted at a ratio of 1:30 in PBS containing 1% BSA. After a 30-min incubation at room temperature in the dark, the cells were stained with propidium iodide, and cellular fluorescence was measured by a FC 500 flow cytometer (Beckman).
Immunofluorescence staining Cells grown on coverslips were fixed using 4% paraformaldehyde solution for 15 min at room temperature, washed with 0.1% NP40/PBS and then extracted with buffer containing 0.5% Triton X-100 for 5 min. Samples were blocked with 5% goat serum and incubated with primary antibody overnight at hSSB1 binds and protects p21 from ubiquitin-mediated degradation S Xu et al 4 1C. The p21 (1:100) and hSSB1 (1:100) antibodies were used to detect endogenous proteins. Samples were washed three times with 0.1% NP40/PBS and incubated with secondary antibody at room temperature for 1 h. Cells were then counterstained with Hoechst 33342 at room temperature for 5 min to visualize nuclear DNA. The coverslips were mounted onto glass slides and visualized by a fluorescence microscope.
Immunohistochemistry Affinity-purified rabbit anti-hSSB1 antibody (IHC-00403, Bethyl Laboratories) was used at a dilution of 1:250. Rabbit monoclonal anti-human p21 (#2947, Cell Signaling Technology) was used at 1:50. Slides were dried overnight at 37 1C, dewaxed in xylene, rehydrated through graded alcohol, and immersed in 3% hydrogen peroxide for 20 min to block endogenous peroxidase activity. An antigen retrieval process was accomplished in a microwave oven with EDTA (pH 8) for 15 min. The slides were incubated with 10% normal goat serum at room temperature for 30 min to reduce nonspecific reaction. Subsequently, the slides were incubated with rabbit polyclonal antibody against hSSB1 and the rabbit monoclonal antibody against p21 for 1 h at 37 1C. After rinsing five times with 0.01 mol/l PBS, pH 7.4 for 10 min, the detection of the primary antibody was achieved with a secondary antibody (Envision; Dako, Glostrup, Denmark) for 1 h at room temperature. The slides were stained with 3,3-diaminobenzidine after washing in PBS again. Finally, the sections were counterstained with Mayer's hematoxylin, dehydrated and mounted. PBS in place of the primary antibody was used as a negative control. A brown particle in the nucleus was considered positive labeling. To evaluate hSSB1and p21 staining, a semi-quantitative scoring criterion was used (Brustmann, 2005) , in which both staining intensity and positive areas were recorded. A staining index (values 0-12), obtained as the product of intensity of positive staining (weak, 1; moderate, 2; strong, 3) and the proportion of immunopositive cells of interest (0%, 0; o10%, 1; 10-50%, 2; 51-80%, 3; 480%, 4) were calculated. Finally, the cases were classified into two different groups: low expression (score 0-6) and high expression (scores 8-12). Statistical analysis was done using SPSS version 13 (SPSS Inc, Chicago, IL, USA). Association between the hSSB1 and p21 abundance was assessed using w 2 -tests.
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